Carbon Pulse: US biotech company moves new livestock methane solution closer to market

In a Carbon Pulse article published May 2, 2025, ArkeaBio CEO Colin South talked with Hailey Clarke about how our vaccine‑based approach can finally unlock scalable methane cuts across the 80% of the world’s pasture‑raised cattle. They discussed how the ArkeaBio team is closing in on market entry, forging global partnerships, and creating a solution […]

S&P Global: ArkeaBio to bring methane reduction vaccine to market before 2030

In an S&P Global story published April 15, 2024, ArkeaBio CEO Colin South spoke with Head of Animal Health Joseph Harvey about ArkeaBio’s plans to bring its cattle methane‑reduction vaccine to market by 2030, offering the first scalable, cost‑effective alternative to feed additives. South and Harvey discussed how advances in biotech tools, plus new carbon‑trading […]

AgFunder: Vaccination is ‘the lowest cost and easiest to scale’ livestock methane reduction solution

ArkeaBio™ Raises $26.5M to Reduce Greenhouse Gas Emissions with Methane Vaccine

Cow burps are a major source of methane emissions. A Boston startup is working on a vaccine to fix that.

Freudenhiem Partners relocates and expands ArkeaBio at 500 Ruthford Ave in Charlestown

How a former diary plant is becoming Boston’s newest destination

Mayor Wu Chamber of Commerce Speech 2023

ArkeaBio™ Nominated for 11th Annual NEVY’s Emerging Climate Tech Company of the Year Award

ArkeaBio™ Honored with Nomination for NEVYs Emerging Climate Tech Company of the Year Award